News | Radiation Therapy | September 22, 2016

Mevion to Spotlight Adaptive Intensity Modulated Proton Therapy at ASTRO 2016

Company will introduce Hyperscan with new adaptive aperture technology allowing faster, sharper and robust pencil beam scanning

Mevion, Hyperscan with Adaptive Aperture, intensity modualted proton therapy, IMPT, ASTRO 2016

September 22, 2016 — Mevion Medical Systems will showcase its pencil beam scanning Hyperscan with Adaptive Aperture at the 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston. The advanced proton micro-multileaf collimator (mMLC) technology is integrated into the Mevion S250i with Hyperscan, making pencil beam scanning sharper and faster and delivering robust intensity modulated proton therapy (IMPT).

Hyperscan with Adaptive Aperture delivers a pencil beam that is up to 50 times faster and 3 times sharper than conventional systems used for IMPT, and can scan a typical lung tumor in less than two seconds. The technology includes a low-profile mMLC system designed specifically for pencil beam scanning that is capable of delivering the sharpest penumbra physically achievable with protons without the need for manual apertures and adjustments, according to Mevion. Its novel layer-by-layer specific beam collimation and blocking achieves 1-3mm collimated spot sizes, for all energies, at any depth.

James Cooley, senior accelerator engineer at Mevion said the new technology is ideal for treating pediatric tumors or shallow brain tumors where small spot sizes have been difficult to achieve by conventional systems.

Mevion is also announcing the growth of its leadership team. The expansion includes the hiring of three industry experts and two internal moves:

  • Yoel Bakas, vice president of sales, Americas, joins Mevion from Varian Medical Systems, where he oversaw strategic account development and has focused on medical devices sales for the past 17 years;
  • Scott Soehl, vice president of international sales, joins Mevion with more than 35 years of radiation oncology experience, having previously worked at Elekta and IMPAC Medical Systems;
  • Curt Kienast, vice president of global services, is promoted from within Mevion where he previously served as senior director of product development. Curt has more than 15 years of experience in healthcare quality and services;
  • Chris Dodge, field vice president, The Americas; business development & customer financing, joins Mevion with 30 years of medical device sales and marketing experience, having previously worked at Varian Medical Systems for the past 15 years; and
  • George Rugg, vice president of business development, is appointed from his previous position as Mevion’s vice president of global services. George’s career spans 30 years of working in the oncology field.

For more information: www.mevion.com

Related Content

Accuray Launches Synchrony Motion Tracking and Correction Technology for Radixact System
Technology | Image Guided Radiation Therapy (IGRT) | April 24, 2019
Accuray announced the launch of its Synchrony motion tracking and correction technology to be used with the Radixact...
New Study Redefines Therapeutic Dose Guidelines for Non-Small Cell Lung Cancer
News | Lung Cancer | April 23, 2019
Non-small cell lung cancer is a common cancer for both men and women. Many people who are diagnosed with this type of...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.
 

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w